Cleared Abbreviated

K171442 - Exofin Fusion Skin Closure System (FDA 510(k) Clearance)

Sep 2017
Decision
132d
Days
Class 2
Risk

K171442 is an FDA 510(k) clearance for the Exofin Fusion Skin Closure System. This device is classified as a Cutaneous Tissue Adhesive With Mesh (Class II - Special Controls, product code OMD).

Submitted by Chemence Medical, Inc. (Alpharetta, US). The FDA issued a Cleared decision on September 25, 2017, 132 days after receiving the submission on May 16, 2017.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4011. For Topical Application Only To Hold Closed Easily Approximated Skin Edges Of Wounds Such As Wounds From Surgical Incisions, Including Punctures From Minimally Invasive Surgery, And Simple Thorough Cleansed, Trauma-induced Lacerations. The Device May Be Used In Conjunction With, But Not In Place Of, Deep Dermal Sutures..

Submission Details

510(k) Number K171442 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2017
Decision Date September 25, 2017
Days to Decision 132 days
Submission Type Abbreviated
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OMD - Cutaneous Tissue Adhesive With Mesh
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4011
Definition For Topical Application Only To Hold Closed Easily Approximated Skin Edges Of Wounds Such As Wounds From Surgical Incisions, Including Punctures From Minimally Invasive Surgery, And Simple Thorough Cleansed, Trauma-induced Lacerations. The Device May Be Used In Conjunction With, But Not In Place Of, Deep Dermal Sutures.